Fulya İlhan

644 total citations
32 papers, 521 citations indexed

About

Fulya İlhan is a scholar working on Immunology, Epidemiology and Rheumatology. According to data from OpenAlex, Fulya İlhan has authored 32 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in Fulya İlhan's work include Ocular Diseases and Behçet’s Syndrome (6 papers), Reproductive System and Pregnancy (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Fulya İlhan is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (6 papers), Reproductive System and Pregnancy (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Fulya İlhan collaborates with scholars based in Türkiye. Fulya İlhan's co-authors include Ahmet Gödekmerdan, Zehra Sema Özkan, Ekrem Sapmaz, Mehmet Şimşek, Handan Akbulut, Figen Deveci, Tamer Demır, Mehmet Hamdi Muz, Peykan Türkçüoğlu and Vedat Bulut and has published in prestigious journals such as Experimental & Molecular Medicine, Mediators of Inflammation and Memórias do Instituto Oswaldo Cruz.

In The Last Decade

Fulya İlhan

29 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fulya İlhan Türkiye 13 213 126 71 71 61 32 521
Huijun Yang China 13 103 0.5× 87 0.7× 97 1.4× 194 2.7× 64 1.0× 39 621
Alper Yurçi Türkiye 15 64 0.3× 215 1.7× 125 1.8× 63 0.9× 18 0.3× 31 685
Małgorzata Banasik Poland 15 446 2.1× 75 0.6× 67 0.9× 63 0.9× 239 3.9× 33 713
Suzanna E.L. Temple Australia 10 139 0.7× 86 0.7× 214 3.0× 102 1.4× 22 0.4× 18 570
Kateřina Štechová Czechia 14 161 0.8× 53 0.4× 130 1.8× 49 0.7× 17 0.3× 55 516
Karey Cheong Australia 16 261 1.2× 178 1.4× 151 2.1× 83 1.2× 13 0.2× 25 947
Georgios Kouklakis Greece 20 169 0.8× 117 0.9× 374 5.3× 113 1.6× 33 0.5× 60 841
Anthony Piron Belgium 5 227 1.1× 156 1.2× 112 1.6× 98 1.4× 11 0.2× 8 591
Elaine Huang Australia 5 778 3.7× 179 1.4× 48 0.7× 97 1.4× 6 0.1× 7 1.1k
Seigo Nagashima Brazil 9 152 0.7× 54 0.4× 53 0.7× 164 2.3× 24 0.4× 41 619

Countries citing papers authored by Fulya İlhan

Since Specialization
Citations

This map shows the geographic impact of Fulya İlhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulya İlhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulya İlhan more than expected).

Fields of papers citing papers by Fulya İlhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fulya İlhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulya İlhan. The network helps show where Fulya İlhan may publish in the future.

Co-authorship network of co-authors of Fulya İlhan

This figure shows the co-authorship network connecting the top 25 collaborators of Fulya İlhan. A scholar is included among the top collaborators of Fulya İlhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fulya İlhan. Fulya İlhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
İlhan, Fulya, et al.. (2022). Are the specific and nonspecific ANA staining patterns of Behçet's Disease patients important?. Reumatología Clínica (English Edition). 18(3). 147–149. 1 indexed citations
2.
Özkan, Zehra Sema, et al.. (2018). The impact of plasma SOCS3 levels and endometrial leukocytes on unexplained infertility. TURKISH JOURNAL OF MEDICAL SCIENCES. 48(3). 509–516. 3 indexed citations
3.
İlhan, Fulya. (2015). Atherosclerosis and the role of immune cells. World Journal of Clinical Cases. 3(4). 345–345. 109 indexed citations
4.
İlhan, Fulya, et al.. (2014). Atopik Dermatitli Hastalarda Total IgE Değerleri. DergiPark (Istanbul University).
5.
Özkan, Zehra Sema, et al.. (2014). What is the impact of SOCS3, IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss?. The Journal of Maternal-Fetal & Neonatal Medicine. 28(3). 324–328. 23 indexed citations
6.
İlhan, Fulya, et al.. (2013). Organ Nakillerinde Regülatör B Hücrelerin Rolü. 6(2). 29–35.
7.
Özkan, Zehra Sema, et al.. (2013). Plasma IL-17, IL-35, interferon-γ, SOCS3 and TGF-β levels in pregnant women with preeclampsia, and their relation with severity of disease. The Journal of Maternal-Fetal & Neonatal Medicine. 27(15). 1513–1517. 51 indexed citations
8.
Özkan, Zehra Sema, et al.. (2013). What is the impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility?. Journal of Reproductive Immunology. 103. 53–58. 49 indexed citations
9.
Kökçam, İbrahim, et al.. (2012). The levels of serum chemokines in patients with Behçet's disease. TURKISH JOURNAL OF MEDICAL SCIENCES. 1 indexed citations
10.
Muz, Mehmet Hamdi, et al.. (2007). Effect of bosentan on the production of proinflammatory cytokines in a rat model of emphysema. Experimental & Molecular Medicine. 39(5). 614–620. 24 indexed citations
11.
Yoldaş, Tahir Kurtuluş, Murat Gönen, Ahmet Gödekmerdan, Fulya İlhan, & Ednan Bayram. (2007). The Serum High-Sensitive C Reactive Protein and Homocysteine Levels to Evaluate the Prognosis of Acute Ischemic Stroke. Mediators of Inflammation. 2007. 1–5. 26 indexed citations
12.
Bahçecioğlu, İbrahim Halil, Hüseyin Ataseven, Erhan Aygen, et al.. (2007). Fasciola Hepatica Case with Hemobilia. Acta Medica (Hradec Kralove Czech Republic). 50(2). 155–156. 4 indexed citations
13.
İlhan, Fulya, et al.. (2007). CD5+ B Cells Ratio In Lepromatous Leprosy. 2 indexed citations
14.
Gödekmerdan, Ahmet, et al.. (2006). Determination of Nuclear Matrix Protein 22 Levels in Cystitis, Urothelial Dysplasia and Urothelial Carcinoma. TURKISH JOURNAL OF MEDICAL SCIENCES. 36(2). 93–96. 5 indexed citations
15.
Deveci, Figen, Handan Akbulut, İ̇lhami Çelik, Mehmet Hamdi Muz, & Fulya İlhan. (2006). Lymphocyte Subpopulations in Pulmonary Tuberculosis Patients. Mediators of Inflammation. 2006(1). 89070–89070. 31 indexed citations
16.
Türkçüoğlu, Peykan, et al.. (2006). The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis. Indian Journal of Ophthalmology. 54(4). 241–241. 20 indexed citations
17.
Yalnız, Mehmet, İbrahim Halil Bahçecioğlu, Hüseyin Ataseven, et al.. (2006). Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis. Mediators of Inflammation. 2006(1). 34295–34295. 46 indexed citations
18.
İlhan, Fulya, Handan Akbulut, Ilgın Karaca, et al.. (2005). Procalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis. Acta Cardiologica. 60(4). 361–365. 22 indexed citations
19.
İlhan, Fulya, et al.. (2005). The Antiphospholipid Antibody Syndrome Research in Patients with Retinal Venous Occlusion. Archives of Medical Research. 36(4). 372–375. 10 indexed citations
20.
İlhan, Fulya, et al.. (2002). Nadir bir kistik ekinokokkozis olgusu. Turkish Journal of Parasitology. 26(4). 403–405. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026